Public‑health data show the 2026‑2027 influenza season is beginning sooner and stronger than typical. The Centers for Disease Control and Prevention (CDC) notes that, as of Oct. 21, flu activity is increasing or likely increasing in 44 states, with moderate levels already reported in Louisiana and Hawaii.
Early surge and the role of H1N1
The CDC’s FluView report for the week ending Oct. 17 described the current level of influenza activity as higher than normally observed at this time of year. While influenza A H3N2 dominated last winter, this season’s cases are being driven primarily by the H1N1 strain, the same virus that caused the 2009 “swine flu” pandemic.
Laboratory analysis indicates that the circulating H1N1 virus has acquired a new mutation, designated G155E, first identified in September in Seattle, Washington. Researchers say this mutation could affect the virus’s ability to evade pre‑existing immunity, potentially making it harder for antibodies from prior infection or vaccination to recognize the virus.
Testing and clinical indicators
During the week ending Oct. 17, 5.7% of flu tests returned positive, compared with less than 1% for the same period last year. Outpatient visits for flu‑like illness reached 2.2%, a figure higher than the previous two seasons. Hospitalizations and deaths related to influenza are also on the rise, though overall numbers remain relatively low.
Expert perspectives
Andrew Pekosz, Ph.D., a virologist at Johns Hopkins Bloomberg School of Public Health, cautioned that the early surge is still in its initial phase. Infectious‑disease physician Dr. Bernard Camins of the Icahn School of Medicine at Mount Sinai noted that the new H1N1 mutation may reduce the protective effect of existing antibodies, especially for children who have not yet been exposed to this strain.
Both experts emphasized that the flu vaccine remains the most effective tool for preventing severe illness. Even if the vaccine’s H1N1 component does not perfectly match the mutated strain, it still offers protection against the other two viruses included in the trivalent formulation – H3N2 and influenza B – and can reduce the severity of illness.
Vaccination recommendations
Health officials recommend that everyone, particularly high‑risk groups such as adults over 65, children under 5, and immunocompromised individuals, receive the flu shot as soon as possible. The vaccine is available at pharmacies, doctors’ offices, and clinics nationwide, with options ranging from standard injections to high‑dose shots, nasal mist, and a new mRNA flu vaccine.
Antiviral medications, which must be prescribed within 48 hours of symptom onset, remain an important treatment option for those who become ill, especially high‑risk patients.
Looking ahead
While an early start does not guarantee a more severe season, public‑health officials will continue to monitor the spread of the mutated H1N1 virus and its impact on vaccine effectiveness. The CDC stresses that flu activity can be unpredictable, underscoring the importance of vaccination and early treatment.
For the best protection, individuals are urged to get vaccinated before the end of October, though later vaccination can still confer benefits. Residents should consult their healthcare providers to determine the most appropriate vaccine type for their needs.
Original reporting: NBC Connecticut — read the source article.
